Khan, Nasreen https://orcid.org/0000-0001-6184-0503
Cabo, Raquel
Tan, Wen-Hann
Tayag, Regina
Bird, Lynne M.
Article History
Received: 24 May 2019
Accepted: 24 September 2019
First Online: 4 November 2019
Ethics approval
: This study was approved by the institutional review boards at each of the institutions where the data were obtained.
: Not applicable.
: Dr. Khan is a paid consultant for Ovid Therapeutics Inc. (Ovid) Ms. Cabo is a paid employee of Ovid . Dr. Tan is participating in clinical trials and has received research supported from Ovid. Ms. Tayag is a paid employee of PROMETRIKA, LLC. PROMETRIKA was paid by Ovid to perform statistical analyses for this paper. Dr. Bird is participating in clinical trials supported by Ovid.